|
US5643567A
(en)
*
|
1990-12-04 |
1997-07-01 |
Board Of Regents, The University Of Texas System |
Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
|
|
NZ240846A
(en)
|
1990-12-06 |
1994-04-27 |
Hoechst Ag |
Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
|
|
ES2087422T3
(es)
|
1991-12-20 |
1996-07-16 |
Hoechst Ag |
Polimeros y oligomeros de derivados de acidos biliares, procedimiento para su preparacion y su empleo como medicamento.
|
|
GB9203347D0
(en)
|
1992-02-17 |
1992-04-01 |
Wellcome Found |
Hypolipidaemic compounds
|
|
ES2111092T3
(es)
|
1992-06-12 |
1998-03-01 |
Hoechst Ag |
Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
|
|
IL108633A
(en)
|
1993-02-15 |
1998-07-15 |
Wellcome Found |
History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them
|
|
IL108634A0
(en)
|
1993-02-15 |
1994-05-30 |
Wellcome Found |
Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
|
|
TW289020B
(https=)
|
1993-05-08 |
1996-10-21 |
Hoechst Sktiengesellschaft |
|
|
TW289021B
(https=)
|
1993-05-08 |
1996-10-21 |
Hoechst Ag |
|
|
TW289757B
(https=)
|
1993-05-08 |
1996-11-01 |
Hoechst Ag |
|
|
EP0624593A3
(de)
|
1993-05-08 |
1995-06-07 |
Hoechst Ag |
Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
|
|
ZA956647B
(en)
|
1994-08-10 |
1997-02-10 |
Wellcome Found |
Hypolipidaemic compounds.
|
|
DK0781278T3
(da)
|
1994-09-13 |
2001-04-17 |
Monsanto Co |
Nye benzothiepiner, som har aktivitet som inhibitorer af ileal galdsyretransport og taurocholatoptagelse
|
|
GB9423172D0
(en)
*
|
1994-11-17 |
1995-01-04 |
Wellcom Foundation The Limited |
Hypolipidemic benzothiazepines
|
|
NZ331813A
(en)
|
1996-03-11 |
2001-03-30 |
G |
Benzothiepine compounds having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
WO1998003818A1
(de)
|
1996-07-24 |
1998-01-29 |
Zumtobel Staff Gmbh |
Adapter für ein haltemittel, welches zum befestigen einer einbauleuchte in einer einbauöffnung bestimmt ist, oder haltemittel oder einbauleuchte mit einem solchen adapter
|
|
DE19633268A1
(de)
|
1996-08-19 |
1998-02-26 |
Hoechst Ag |
Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung
|
|
MXPA99008417A
(es)
|
1997-03-11 |
2005-02-03 |
Searle & Co |
Terapia de combinacion que emplaza benzotiepinas inhibidoras de transporte de acido biliar ileal e inhibidores de hmg co-a reductasa.
|
|
DE69815180T2
(de)
|
1997-03-14 |
2004-04-29 |
Aventis Pharma Deutschland Gmbh |
Hypolipidemische 1,4-Benzothiazepin-1,1-dioxide
|
|
GB9800428D0
(en)
|
1998-01-10 |
1998-03-04 |
Glaxo Group Ltd |
Chemical compounds
|
|
DE19825804C2
(de)
|
1998-06-10 |
2000-08-24 |
Aventis Pharma Gmbh |
1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
JP2002533414A
(ja)
|
1998-12-23 |
2002-10-08 |
ジー．ディー．サール エルエルシー |
心臓血管に適用するための回腸胆汁酸輸送阻害剤および胆汁酸隔離剤の組み合わせ
|
|
PL348508A1
(en)
|
1998-12-23 |
2002-05-20 |
Searle Llc |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
|
|
DE69911058T2
(de)
|
1998-12-23 |
2004-06-03 |
G.D. Searle Llc, Chicago |
Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen
|
|
EP1140191B1
(en)
|
1998-12-23 |
2002-10-23 |
G.D. Searle LLC. |
Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
|
|
CN1342090A
(zh)
|
1998-12-23 |
2002-03-27 |
G·D·瑟尔有限公司 |
适用于心血管疾病的回肠胆汁酸转运抑制剂和贝酸衍生物的组合
|
|
CA2362147A1
(en)
|
1999-02-12 |
2000-08-17 |
Steve A. Kolodziej |
1,2-benzothiazepines for the treatment of hyperlipidemic diseases
|
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
SE9901387D0
(sv)
|
1999-04-19 |
1999-04-19 |
Astra Ab |
New pharmaceutical foromaulations
|
|
SE0000772D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
Chemical compounds
|
|
AU2001247331A1
(en)
|
2000-03-10 |
2001-09-24 |
Pharmacia Corporation |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
|
SE0003766D0
(sv)
|
2000-10-18 |
2000-10-18 |
Astrazeneca Ab |
Novel formulation
|
|
EG26979A
(en)
*
|
2000-12-21 |
2015-03-01 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121337D0
(en)
*
|
2001-09-04 |
2001-10-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121621D0
(en)
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121622D0
(en)
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
TWI331143B
(en)
|
2001-09-08 |
2010-10-01 |
Astrazeneca Uk Ltd |
Benzothiadiazepine derivatives, process for preparing them, and pharmaceutical composition comprising them
|
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
|
GB0209467D0
(en)
|
2002-04-25 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0213669D0
(en)
|
2002-06-14 |
2002-07-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0216321D0
(en)
|
2002-07-13 |
2002-08-21 |
Astrazeneca Ab |
Therapeutic treatment
|
|
AU2003257578B2
(en)
|
2002-08-28 |
2009-01-22 |
Asahi Kasei Pharma Corporation |
Novel quaternary ammonium compounds
|
|
GB0304194D0
(en)
|
2003-02-25 |
2003-03-26 |
Astrazeneca Ab |
Chemical compounds
|
|
US20050215882A1
(en)
|
2004-03-23 |
2005-09-29 |
The Regents Of The University Of Michigan |
Noninvasive method to determine fat content of tissues using MRI
|
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
|
US9295677B2
(en)
|
2008-02-26 |
2016-03-29 |
Qing Bile Therapeutics Inc. |
Polyhydroxylated bile acids for treatment of biliary disorders
|
|
JO3131B1
(ar)
|
2010-04-27 |
2017-09-20 |
Glaxosmithkline Llc |
مركبات كيميائية
|
|
EP3110507B1
(en)
|
2014-02-27 |
2020-11-18 |
NuSirt Sciences, Inc. |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
|
KR20160061492A
(ko)
|
2014-11-21 |
2016-06-01 |
삼성디스플레이 주식회사 |
휴대용 먼지 센서 및 이를 이용한 휴대전화
|
|
RU2750937C2
(ru)
|
2016-02-09 |
2021-07-06 |
Альбирео Аб |
Пероральный состав холестирамина и его применение
|
|
EP3413877B1
(en)
|
2016-02-09 |
2021-04-07 |
Albireo AB |
Oral cholestyramine formulation and use thereof
|
|
US11350844B2
(en)
|
2016-11-23 |
2022-06-07 |
Mayo Foundation For Medical Education And Research |
System and method for generating nonalcoholic fatty liver disease activity score (NAS) using magnetic resonance elastography
|
|
CA3071182A1
(en)
|
2017-08-09 |
2019-02-14 |
Albireo Ab |
Cholestyramine pellets, oral cholestyramine formulations and use thereof
|
|
JP2020530448A
(ja)
|
2017-08-09 |
2020-10-22 |
アルビレオ・アクチボラグ |
コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
|
|
ES2942443T3
(es)
|
2018-06-05 |
2023-06-01 |
Albireo Ab |
Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares
|